MAPPX
Price
$26.86
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Net Assets
221.42M
VIGRX
Price
$237.87
Change
-$0.79 (-0.33%)
Updated
Aug 15 closing price
Net Assets
324.3B
Interact to see
Advertisement

MAPPX vs VIGRX

Header iconMAPPX vs VIGRX Comparison
Open Charts MAPPX vs VIGRXBanner chart's image
Morgan Stanley Inst Advantage A
Price$26.86
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets221.42M
Vanguard Growth Index Investor
Price$237.87
Change-$0.79 (-0.33%)
VolumeN/A
Net Assets324.3B
MAPPX vs VIGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MAPPX vs. VIGRX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAPPX is a Hold and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 324B vs. MAPPX (221M). MAPPX pays higher dividends than VIGRX: MAPPX (1.05) vs VIGRX (0.32). MAPPX was incepted earlier than VIGRX: MAPPX (15 years) vs VIGRX (33 years). MAPPX (1.29) is less costly to investors than VIGRX (0.17). MAPPX is a more actively managed with annual turnover of: 57.00 vs. VIGRX (11.00). MAPPX has a lower initial minimum investment than VIGRX: MAPPX (1000) vs VIGRX (3000). MAPPX annual gain was more profitable for investors over the last year : 55.92 vs. VIGRX (24.03). VIGRX return over 5 years is better than : 107.21 vs. MAPPX (-25.38).
MAPPXVIGRXMAPPX / VIGRX
Total Expense Ratio1.200.17706%
Annual Report Gross Expense Ratio1.290.17759%
Fund Existence15 years33 years-
Gain YTD19.91112.580158%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets221M324B0%
Annual Yield % from dividends1.050.32326%
Returns for 1 year55.9224.03233%
Returns for 3 years35.4273.6848%
Returns for 5 years-25.38107.21-24%
Returns for 10 years47.38321.5115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR27.260.57
+2.14%
Nektar Therapeutics
SUPN42.690.52
+1.23%
Supernus Pharmaceuticals
FTAI144.72-0.18
-0.12%
FTAI Aviation Ltd
SBFM1.49-0.02
-1.33%
Sunshine Biopharma Inc
AXTI2.05-0.11
-5.09%
AXT